- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x CLQ: N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE(Non-covalent)
- 12 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 6 residues within 4Å:- Chain A: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.317, A:R.317, A:M.319, A:R.373
- Water bridges: A:R.126
GOL.3: 10 residues within 4Å:- Chain A: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.1
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:F.104, A:V.105, A:S.141, A:Y.146
- Water bridges: A:F.422, A:F.422
GOL.9: 6 residues within 4Å:- Chain B: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.317, B:R.317, B:M.319, B:R.373
- Water bridges: B:R.126
GOL.10: 10 residues within 4Å:- Chain B: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.8
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:F.104, B:V.105, B:S.141, B:Y.146
- Water bridges: B:F.422, B:F.422
GOL.16: 6 residues within 4Å:- Chain C: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:R.317, C:R.317, C:M.319, C:R.373
- Water bridges: C:R.126
GOL.17: 10 residues within 4Å:- Chain C: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.15
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:F.104, C:V.105, C:S.141, C:Y.146
- Water bridges: C:F.422, C:F.422
GOL.23: 6 residues within 4Å:- Chain D: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:R.317, D:R.317, D:M.319, D:R.373
- Water bridges: D:R.126
GOL.24: 10 residues within 4Å:- Chain D: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.22
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:F.104, D:V.105, D:S.141, D:Y.146, D:Y.146
- Water bridges: D:F.422, D:F.422
GOL.30: 6 residues within 4Å:- Chain E: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain E- Hydrogen bonds: E:R.317, E:R.317, E:M.319, E:R.373
- Water bridges: E:R.126
GOL.31: 10 residues within 4Å:- Chain E: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.29
7 PLIP interactions:7 interactions with chain E- Hydrogen bonds: E:F.104, E:V.105, E:S.141, E:Y.146, E:Y.146
- Water bridges: E:F.422, E:F.422
GOL.37: 6 residues within 4Å:- Chain F: H.125, R.126, A.129, R.317, M.319, R.373
5 PLIP interactions:5 interactions with chain F- Hydrogen bonds: F:R.317, F:R.317, F:M.319, F:R.373
- Water bridges: F:R.126
GOL.38: 10 residues within 4Å:- Chain F: F.44, L.102, S.103, F.104, V.105, H.139, A.140, S.141, Y.146
- Ligands: CLQ.36
7 PLIP interactions:7 interactions with chain F- Hydrogen bonds: F:F.104, F:V.105, F:S.141, F:Y.146, F:Y.146
- Water bridges: F:F.422, F:F.422
- 24 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.4: 5 residues within 4Å:- Chain A: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.5: 9 residues within 4Å:- Chain A: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.6
Ligand excluded by PLIPPEG.6: 8 residues within 4Å:- Chain A: A.263, V.264, T.265, A.266, H.269, P.294
- Chain E: A.391
- Ligands: PEG.5
Ligand excluded by PLIPPEG.7: 6 residues within 4Å:- Chain A: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIPPEG.11: 5 residues within 4Å:- Chain B: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.12: 9 residues within 4Å:- Chain B: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.13
Ligand excluded by PLIPPEG.13: 8 residues within 4Å:- Chain B: A.263, V.264, T.265, A.266, H.269, P.294
- Chain D: A.391
- Ligands: PEG.12
Ligand excluded by PLIPPEG.14: 6 residues within 4Å:- Chain B: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIPPEG.18: 5 residues within 4Å:- Chain C: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.19: 9 residues within 4Å:- Chain C: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.20
Ligand excluded by PLIPPEG.20: 8 residues within 4Å:- Chain C: A.263, V.264, T.265, A.266, H.269, P.294
- Chain F: A.391
- Ligands: PEG.19
Ligand excluded by PLIPPEG.21: 6 residues within 4Å:- Chain C: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIPPEG.25: 5 residues within 4Å:- Chain D: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.26: 9 residues within 4Å:- Chain D: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.27
Ligand excluded by PLIPPEG.27: 8 residues within 4Å:- Chain B: A.391
- Chain D: A.263, V.264, T.265, A.266, H.269, P.294
- Ligands: PEG.26
Ligand excluded by PLIPPEG.28: 6 residues within 4Å:- Chain D: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIPPEG.32: 5 residues within 4Å:- Chain E: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.33: 9 residues within 4Å:- Chain E: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.34
Ligand excluded by PLIPPEG.34: 8 residues within 4Å:- Chain A: A.391
- Chain E: A.263, V.264, T.265, A.266, H.269, P.294
- Ligands: PEG.33
Ligand excluded by PLIPPEG.35: 6 residues within 4Å:- Chain E: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIPPEG.39: 5 residues within 4Å:- Chain F: T.58, L.59, V.60, P.61, D.86
Ligand excluded by PLIPPEG.40: 9 residues within 4Å:- Chain F: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
- Ligands: PEG.41
Ligand excluded by PLIPPEG.41: 8 residues within 4Å:- Chain C: A.391
- Chain F: A.263, V.264, T.265, A.266, H.269, P.294
- Ligands: PEG.40
Ligand excluded by PLIPPEG.42: 6 residues within 4Å:- Chain F: S.259, R.262, I.288, T.418, A.419, F.420
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-01
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x CLQ: N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE(Non-covalent)
- 12 x GOL: GLYCEROL(Non-functional Binders)
- 24 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-01
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A